These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3367950

  • 1. Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies.
    Steis RG, Smith JW, Urba WJ, Clark JW, Itri LM, Evans LM, Schoenberger C, Longo DL.
    N Engl J Med; 1988 Jun 02; 318(22):1409-13. PubMed ID: 3367950
    [Abstract] [Full Text] [Related]

  • 2. Hairy cell leukemia: a model for studying the B cell family of diseases.
    Al-Katib A, Berman E, Black P, Koziner B.
    Semin Oncol; 1986 Dec 02; 13(4 Suppl 5):48-54. PubMed ID: 3492047
    [Abstract] [Full Text] [Related]

  • 3. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D, Levo Y, Rahmani R, Mory Y, Vaks B, Horowitz O, Doerner T, Shoham J, Wallach D, Revel M.
    Isr J Med Sci; 1985 Dec 02; 21(12):977-81. PubMed ID: 4093298
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of hairy-cell leukemia using interferon alfa].
    Neuwirtová R, Cermák J, Kvasnicka J, Sedlácková M.
    Cas Lek Cesk; 1989 Aug 18; 128(34):1065-70. PubMed ID: 2790914
    [Abstract] [Full Text] [Related]

  • 5. Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemia.
    Steis RG, Smith JW, Urba WJ, Venzon DJ, Longo DL, Barney R, Evans LM, Itri LM, Ewel CH.
    Blood; 1991 Feb 15; 77(4):792-8. PubMed ID: 1704264
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of neutralizing antibodies in patients treated with recombinant interferon-beta ser.
    Larocca AP, Leung SC, Marcus SG, Colby CB, Borden EC.
    J Interferon Res; 1989 Sep 15; 9 Suppl 1():S51-60. PubMed ID: 2809278
    [Abstract] [Full Text] [Related]

  • 7. Biologic response modifiers: the interferon alfa experience.
    Koeller JM.
    Am J Hosp Pharm; 1989 Nov 15; 46(11 Suppl 2):S11-5. PubMed ID: 2481396
    [Abstract] [Full Text] [Related]

  • 8. Intron A (interferon alfa-2b): clinical overview and future directions.
    Spiegel RJ.
    Semin Oncol; 1986 Sep 15; 13(3 Suppl 2):89-101. PubMed ID: 3532338
    [Abstract] [Full Text] [Related]

  • 9. [Use of alpha-interferon in the treatment of patients with hairy cell leukemia].
    Gotić M, Rolović Z, Vuković S, Elezović I, Tomić D.
    Srp Arh Celok Lek; 1990 Sep 15; 118(7-8):277-84. PubMed ID: 2097776
    [Abstract] [Full Text] [Related]

  • 10. INTRON A (interferon alfa-2b): clinical overview.
    Spiegel RJ.
    Cancer Treat Rev; 1985 Dec 15; 12 Suppl B():5-16. PubMed ID: 3914355
    [No Abstract] [Full Text] [Related]

  • 11. Antibodies to interferon-alpha 2 in patients treated with interferon-alpha 2 for hairy cell leukemia.
    Bekisz JB, zur Nedden DL, Enterline JC, Zoon KC.
    J Interferon Res; 1989 Sep 15; 9 Suppl 1():S1-7. PubMed ID: 2809275
    [Abstract] [Full Text] [Related]

  • 12. The alpha interferons: clinical overview.
    Spiegel RJ.
    Semin Oncol; 1987 Jun 15; 14(2 Suppl 2):1-12. PubMed ID: 3296210
    [Abstract] [Full Text] [Related]

  • 13. The UCLA experience with type I interferons in hairy cell leukemia.
    Glaspy JA, Jacobs AD, Golde DW.
    Leukemia; 1987 Apr 15; 1(4):323-6. PubMed ID: 3312839
    [Abstract] [Full Text] [Related]

  • 14. Natural leukocyte interferon-alpha therapy in patients with chronic granulocytic leukemia who have antibody-mediated resistance to treatment with recombinant interferon-alpha.
    Tefferi A, Grendahl DC.
    Am J Hematol; 1996 Jul 15; 52(3):231-3. PubMed ID: 8756097
    [Abstract] [Full Text] [Related]

  • 15. Hairy cell leukemia: an interferon deficient disease?
    Hofmann V, Fehr J, Sauter C, Ottino J.
    Cancer Treat Rev; 1985 Dec 15; 12 Suppl B():33-7. PubMed ID: 3833328
    [Abstract] [Full Text] [Related]

  • 16. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
    Thompson JA, Brady J, Kidd P, Fefer A.
    Cancer Treat Rep; 1985 Dec 15; 69(7-8):791-3. PubMed ID: 4016788
    [Abstract] [Full Text] [Related]

  • 17. Epitopes recognized by neutralizing therapy-induced human anti-interferon-alpha antibodies are localized within the N-terminal functional domain of recombinant interferon-alpha 2.
    Nolte KU, Günther G, von Wussow P.
    Eur J Immunol; 1996 Sep 15; 26(9):2155-9. PubMed ID: 8814261
    [Abstract] [Full Text] [Related]

  • 18. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
    Quesada JR, Lepe-Zuniga JL, Gutterman JU.
    Leukemia; 1987 Apr 15; 1(4):317-9. PubMed ID: 3669753
    [Abstract] [Full Text] [Related]

  • 19. Anti-interferon antibodies to interferon-alpha 2b: results of comparative assays and clinical perspective.
    Spiegel RJ, Jacobs SL, Treuhaft MW.
    J Interferon Res; 1989 Sep 15; 9 Suppl 1():S17-24. PubMed ID: 2553829
    [Abstract] [Full Text] [Related]

  • 20. Antibodies in patients with hairy-cell leukemia receiving alpha-2b interferon.
    Jacobs SL, Kelsey DK.
    N Engl J Med; 1986 Nov 27; 315(22):1418. PubMed ID: 3773970
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.